Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats

DOI Web Site Web Site PubMed 被引用文献2件 参考文献69件
  • Ozawa Shogo
    Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University
  • Gamou Toshie
    Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University
  • Habano Wataru
    Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University
  • Inoue Kaoru
    Division of Pathology, National Institute of Health Sciences
  • Yoshida Midori
    Division of Pathology, National Institute of Health Sciences
  • Nishikawa Akiyoshi
    Division of Pathology, National Institute of Health Sciences
  • Nemoto Kiyomitsu
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
  • Degawa Masakuni
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka

この論文をさがす

抄録

The purpose of our study was to examine the altered gene expression associated with nongenotoxic chemical-mediated liver hypertrophy and successive liver tumor promotion. Five-week-old male rats were fed a basal diet or a diet containing phenobarbital (PB) or clofibrate (CF) for 3 days, 4 weeks, and 13 weeks. Hepatic expression profiling of cell growth- and stress-related genes, as well as those involved in xenobiotic metabolism, was performed by DNA microarray and/or real time quantitative reverse transcription-polymerase chain reaction. The induction of liver hypertrophy and hepatic cytochrome P450 (CYP) isoforms (CYP2B1/2B2 for PB and CYP4A1 for CF) by PB and CF were clearly observed at all the treatment periods examined. Genes encoding DNA damage-inducible 45 (GADD45) family proteins, in particular GADD45g (GADD45 gamma) were down-regulated by treatment with either PB or CF for 4 and 13 weeks. The chemical-mediated development of liver hypertrophy, induction of hepatic CYPs, and suppression of hepatic GADD45g gene at week 13 disappeared at 4 weeks following cessation of the chemical treatment. Additionally, DNA microarray data indicated that cell cycle-related genes such as cyclins CCNB1 and CCNA2 and cyclin-dependent kinase inhibitor CDKN3 were also down-regulated by treatment with either PB or CF at 13 weeks. Since GADD45 functions as a chemical and radiation stress sensor by interacting with cyclins and cyclin-dependent kinase inhibitors, the decrease in the gene expression of GADD45g mRNA observed in this study, may be associated with nongenotoxic chemical-induced tumor promotion of hepatocarcinogenesis rather than liver hypertrophy. 

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (69)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ